Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02241226 · ClinicalTrials.gov registry record · NA

Self-Directed Biological Transformation Initiative

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
115
Enrollment target

NCT02241226: Completed NA study, sponsored by University of California, San Diego.

NCT02241226 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02241226, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target

Study Summary

It is becoming increasingly recognized in the literature that ancient practices for wellbeing, including meditation, yoga, and specific herbs, can improve health and promote longevity. While studies have documented such effects for a variety of individual practices for wellbeing, few studies have taken a more whole systems approach that is simultaneously inclusive of numerous practices. This intervention study, the "Self-Directed Biological Transformation Initiative", will examine the effects of a comprehensive whole systems approach to wellbeing on key biochemical, physiological, and psychosocial endpoints. Participants randomized to the Perfect Health program at the Chopra Center for Wellbeing will be compared to individuals not taking the program.

Primary Outcome

Blood samples will be collected for RNA expression and assayed using standardized methodologies

Interventions

  • BEHAVIORAL Perfect Health Course

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2014-09
Est. Completion 2015-02
Phase NA
University of California, San Diego

775 total trials

What the finished NCT02241226 record still lists

NCT02241226 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Perfect Health Course is the first listed.

NCT02241226 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02241226 about?

NCT02241226 is a clinical study titled "Self-Directed Biological Transformation Initiative". It is becoming increasingly recognized in the literature that ancient practices for wellbeing, including meditation, yoga, and specific herbs, can improve health and promote longevity. While studies have documented such effects for a variety of individual practices for wellbeing, few studies have ta...

What is the current status of trial NCT02241226?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2014-09. Estimated completion is 2015-02.

What interventions are being tested in trial NCT02241226?

The interventions under investigation include: Perfect Health Course (BEHAVIORAL).

Who is sponsoring clinical trial NCT02241226?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02241226's enrollment target sits among peer trials

115 810th of 2000 higher than 1,190 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02346929 · 115 participants · NA

    Hematoma Block for Distal Radius Fracture

  • NCT03394365 · 115 participants · Phase 3

    A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  • NCT03907475 · 115 participants · Phase 2

    Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

  • NCT05086692 · 115 participants · Phase 1

    A Beta-only IL-2 ImmunoTherapY Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02241226, the US trial registry maintained by the National Library of Medicine. NCT02241226 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.